Medical Care Technologies Inc. Moves Into Apple's Final TestFlight Testing Phase for Its Debut Consumer AI App
Rhea-AI Summary
Medical Care Technologies (OTC PINK: MDCE) announced on December 1, 2025 that its first consumer AI mobile application has entered Apple iOS TestFlight, described as the final testing phase before App Store release. The app targets a $13.4 billion global health and nutrition app market and represents MDCE's first major consumer product outside its medical roadmap.
The company plans a sequential rollout: complete iOS TestFlight, obtain App Store approval and launch iOS, begin Google Play testing, then pursue a global Android launch after Google approval. Management said the app showcases internal development and AI capabilities and that a leading marketing agency will be engaged at launch. MDCE will provide ongoing investor updates as testing and feature refinement continue.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, MDCE declined 25.00%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
MDCE fell 16.67% while close peers were mixed: YUKA at -5.45%, BBTT at +1.52%, and others flat. Moves do not indicate a unified sector trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 10 | AI authentication milestone | Positive | -16.7% | Subsidiary Real Game Used validated AI-based sports memorabilia authentication scale. |
| Dec 09 | Share structure & partnership | Positive | -14.3% | Share structure stabilization and new tech partnership with AI health tools focus. |
| Dec 08 | AI dermatology integration | Positive | +0.0% | Integration of Google-backed Derm Foundation into skin and wound monitoring app. |
| Dec 05 | Reg A completion | Positive | +40.0% | Conclusion of Reg A offering and shift toward 2026 AI product and revenue expansion. |
| Dec 04 | AI strategy update | Positive | +0.0% | Strategic acceleration toward AI health, nutrition, wellness, and food intelligence apps. |
Recent MDCE news has been consistently positive, but price reactions have been mixed, including notable selloffs on favorable AI and capital-structure updates.
Over the last week, MDCE issued several updates on AI initiatives and capital structure. On Dec 4, it highlighted a shift toward AI health and wellness apps leveraging subsidiaries Infinite Auctions and Real Game Used. On Dec 5, it announced the close of a Reg A offering, ending dilution and funding 2026 AI product launches, which coincided with a 40% move. Subsequent AI and partnership updates on Dec 8–10 saw neutral to negative reactions, underscoring inconsistent trading responses to positive news.
Market Pulse Summary
The stock dropped -25.0% in the session following this news. A negative reaction despite operational progress would fit MDCE’s recent pattern, where upbeat AI and share-structure news still saw declines of 14–17%. The TestFlight update advances the debut consumer AI app toward launch, but the stock already trades 83.33% below its 52-week high. Execution risk around App Store approval, Android rollout, marketing effectiveness, and eventual monetization of the AI app suite could have contributed to skepticism despite the milestone.
AI-generated analysis. Not financial advice.
"MDCE Aims at a
MESA, ARIZONA / ACCESS Newswire / December 1, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) is pleased to announce that its first consumer-based mobile application-designed to showcase the company's expanding technological capabilities-is now deep into Apple's iOS TestFlight testing phase, the final stage before public release on the App Store.
This artificial-intelligence-powered application introduces a unique twist within the global multi-billion-dollar food and cuisine mobile app sector, representing MDCE's first major step into mass-market consumer technology. The company will reveal the official name of the application upon launch, and MDCE is preparing to engage a leading marketing agency specializing in worldwide mobile app releases.
"Reaching the TestFlight milestone demonstrates the strength of our internal development team," said Marshall Perkins III, CEO of Medical Care Technologies Inc. "This first consumer application is a testament to our coding expertise and early AI capabilities. We believe it will have the potential to generate revenue in several countries as we continue to build an expanding library of AI-driven applications set for release over the coming quarters."
MDCE's development roadmap includes the following sequential steps:
Complete the iOS TestFlight evaluation;
Obtain Apple App Store approval and launch the iOS version;
Immediately begin the Google Play testing phase;
Upon Google's approval, proceed with the official global Android launch.
The company will continue providing regular updates to investors regarding the status of both its consumer-focused AI application and its upcoming AI-based medical applications as testing progresses and features are refined.
About Medical Care Technologies Inc. (MDCE)
Medical Care Technologies Inc. (OTC PINK: MDCE) is an emerging technology company focused on developing artificial intelligence-based applications across health, consumer, and enterprise sectors. Leveraging advanced computer vision, machine learning, and mobile software architecture, MDCE builds scalable digital products with global commercial potential. The company is headquartered in Mesa, Arizona. For more information, please visit www.medicalcaretechnologies.com.
Safe Harbor Statement
This press release contains forward-looking statements based on current expectations and assumptions. Actual results may differ due to risks and uncertainties related to regulatory approvals, market conditions, product performance, and operational factors. The company undertakes no obligation to update such statements except as required by law.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
What did Medical Care Technologies (MDCE) announce on December 1, 2025 about its new app?
What is MDCE's rollout plan and timeline for the new AI consumer app (MDCE)?
How large is the market MDCE is targeting with its first AI consumer app (MDCE)?
Will Medical Care Technologies hire outside help to launch the MDCE consumer app?
Does MDCE's December 1, 2025 announcement confirm App Store or Google Play approvals for the new app?
